1. Home
  2. ADTX vs ATCH Comparison

ADTX vs ATCH Comparison

Compare ADTX & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • ATCH
  • Stock Information
  • Founded
  • ADTX 2017
  • ATCH 2022
  • Country
  • ADTX United States
  • ATCH United States
  • Employees
  • ADTX N/A
  • ATCH N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • ATCH
  • Sector
  • ADTX Health Care
  • ATCH
  • Exchange
  • ADTX Nasdaq
  • ATCH Nasdaq
  • Market Cap
  • ADTX 3.1M
  • ATCH 3.0M
  • IPO Year
  • ADTX 2020
  • ATCH N/A
  • Fundamental
  • Price
  • ADTX $1.39
  • ATCH $0.19
  • Analyst Decision
  • ADTX
  • ATCH
  • Analyst Count
  • ADTX 0
  • ATCH 0
  • Target Price
  • ADTX N/A
  • ATCH N/A
  • AVG Volume (30 Days)
  • ADTX 1.2M
  • ATCH 2.7M
  • Earning Date
  • ADTX 08-18-2025
  • ATCH 05-16-2025
  • Dividend Yield
  • ADTX N/A
  • ATCH N/A
  • EPS Growth
  • ADTX N/A
  • ATCH N/A
  • EPS
  • ADTX N/A
  • ATCH 2.67
  • Revenue
  • ADTX $55,323.00
  • ATCH N/A
  • Revenue This Year
  • ADTX $15,768.94
  • ATCH N/A
  • Revenue Next Year
  • ADTX N/A
  • ATCH N/A
  • P/E Ratio
  • ADTX N/A
  • ATCH $0.07
  • Revenue Growth
  • ADTX N/A
  • ATCH N/A
  • 52 Week Low
  • ADTX $1.28
  • ATCH $0.18
  • 52 Week High
  • ADTX $27,200.00
  • ATCH $66.00
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 44.87
  • ATCH 34.16
  • Support Level
  • ADTX $1.28
  • ATCH $0.18
  • Resistance Level
  • ADTX $2.19
  • ATCH $0.20
  • Average True Range (ATR)
  • ADTX 0.15
  • ATCH 0.02
  • MACD
  • ADTX 0.08
  • ATCH 0.01
  • Stochastic Oscillator
  • ADTX 30.77
  • ATCH 10.53

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: